E.I.D.- Parry (India) Limited (EIDPARRY.NS)
Chennai, IN
E.I.D.- Parry (India) Limited is a diversified enterprise that, along with its various subsidiaries, focuses on manufacturing and distributing sugar, nutraceuticals, and sanitization products. The company operates both within India and on the international stage. Its sugar products are supplied to a broad spectrum of industries, including food production, baking, confectionery, beverage manufacturing, and pharmaceuticals. Furthermore, E.I.D.- Parry offers a comprehensive range of nutraceuticals, such as organic spirulina and chlorella, carotenoids, astaxanthin, and lutein and zeaxanthin. Beyond these core areas, the firm also provides hand sanitization solutions and has a power generation capacity of approximately 140 MW. Tracing its origins back to 1788, the company maintains its headquarters in Chennai, India.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +2.37% | -3.17% | -9.83% | -12.04% | -26.18% | -26.45% | -20.05% | +61.49% | +82.04% | +224.45% | +10,142.26% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Agricultural Inputs: +9.5%+64.5% ★ Q1'26: +671.0% (vs Q1'25)
-
EPS growth Agricultural Inputs: +23.0%-35.3% Q1'26: -216.0% (vs Q1'25)
-
FCF margin FCF growth · Agricultural Inputs: +27.6%+0.8% Q1'26: +26.2% (vs Q1'25)
-
EBIT margin Agricultural Inputs: +9.7%+7.0% Q1'26: +1.1% (vs Q1'25)
-
ROIC Agricultural Inputs: +7.4%+11.7% ★ Q1'26: +2.3% (vs Q1'25)
-
Share dilution Agricultural Inputs: +0.0%+0.2% Q1'26: +0.5% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Agricultural Inputs: 0.03×1.02× Q1'26: 2.84× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2005 actual |
Mar 2006 actual |
Mar 2007 actual |
Mar 2008 actual |
Mar 2009 actual |
Mar 2011 actual |
Mar 2012 actual |
Mar 2013 actual |
Mar 2014 actual |
Mar 2015 actual |
Mar 2016 actual |
Mar 2017 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 1 Rev. Ana. 1 EPS Ana. |
Mar 2027 1 Rev. Ana. 1 EPS Ana. |
Mar 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
22.37B
est: 7.04B (+217.9%)
|
28.85B
est: 9.05B (+218.8%)
|
27.68B
est: 6.29B (+340.4%)
|
27.86B
est: 5.42B (+413.8%)
|
103.17B
est: 7.91B (+1,204.4%)
|
93.60B
est: 13.02B (+619.2%)
|
76.10B
est: 14.45B (+426.6%)
|
83.22B
est: 20.15B (+312.9%)
|
91.72B
est: 20.17B (+354.7%)
|
106.80B
est: 21.21B (+403.5%)
|
119.08B
est: 19.96B (+496.5%)
|
118.46B
est: 25.61B (+362.6%)
|
125.94B
est: 20.45B (+515.9%)
|
132.92B
est: 21.20B (+527.1%)
|
137.11B
est: 16.42B (+735.0%)
|
151.03B
est: 14.13B (+969.3%)
|
166.53B
est: 22.96B (+625.2%)
|
206.81B
est: 27.37B (+655.6%)
|
211.95B
est: 29.43B (+620.2%)
|
234.19B
est: 31.16B (+651.5%)
|
361.04B
361.04B – 361.04B
+1,058.5% YoY
|
367.82B
367.82B – 367.82B
+1.9% YoY
|
395.40B
395.40B – 395.40B
+7.5% YoY
|
| EBITDA |
3.21B
est: 1.03B (+212.2%)
|
3.63B
est: 3.36B (+8.1%)
|
4.20B
est: 1.99B (+110.8%)
|
4.94B
est: 777.52M (+535.9%)
|
18.96B
est: 3.52B (+438.8%)
|
12.07B
est: 5.79B (+108.5%)
|
12.32B
est: 6.77B (+82.1%)
|
10.52B
est: 5.19B (+102.8%)
|
8.80B
est: 1.16B (+655.2%)
|
10.98B
est: -1.42B (+872.3%)
|
9.93B
est: 198.89M (+4,891.5%)
|
15.66B
est: -1.58B (+1,093.4%)
|
14.33B
est: 4.92B (+191.3%)
|
15.10B
est: 4.81B (+214.0%)
|
19.99B
est: 2.40B (+732.1%)
|
20.88B
est: 7.65B (+172.8%)
|
25.96B
est: 3.36B (+672.8%)
|
32.16B
est: 8.97B (+258.3%)
|
28.59B
est: 4.30B (+564.2%)
|
33.02B
est: 4.22B (+682.8%)
|
48.87B
48.87B – 48.87B
+1,058.5% YoY
|
49.79B
49.79B – 49.79B
+1.9% YoY
|
53.52B
53.52B – 53.52B
+7.5% YoY
|
| EBIT |
2.58B
est: 885.82M (+191.2%)
|
2.96B
est: 2.16B (+36.9%)
|
3.43B
est: 1.58B (+117.4%)
|
3.91B
est: 669.19M (+484.9%)
|
17.89B
est: 4.32B (+314.0%)
|
10.33B
est: 7.11B (+45.2%)
|
10.42B
est: 9.00B (+15.8%)
|
8.37B
est: 16.47B (-49.2%)
|
6.53B
est: 10.25B (-36.3%)
|
8.53B
est: 10.01B (-14.7%)
|
7.43B
est: 8.97B (-17.1%)
|
13.19B
est: 10.71B (+23.1%)
|
11.82B
est: 11.07B (+6.8%)
|
12.44B
est: 9.00B (+38.2%)
|
16.81B
est: 11.46B (+46.7%)
|
17.56B
est: 1.78B (+887.6%)
|
22.62B
est: 2.89B (+682.5%)
|
28.39B
est: 21.84B (+30.0%)
|
24.39B
est: 3.70B (+558.2%)
|
27.92B
est: 3.60B (+676.1%)
|
41.67B
41.67B – 41.67B
+1,058.5% YoY
|
42.46B
42.46B – 42.46B
+1.9% YoY
|
45.64B
45.64B – 45.64B
+7.5% YoY
|
| Net Income |
1.55B
est: 802.00M (+92.9%)
|
1.72B
est: 1.99B (-13.8%)
|
2.20B
est: 1.19B (+84.5%)
|
1.05B
est: -298.20M (+451.2%)
|
11.63B
est: 1.53B (+661.8%)
|
5.55B
est: 2.51B (+120.8%)
|
3.13B
est: 3.47B (-9.8%)
|
2.07B
est: 4.36B (-52.5%)
|
779.70M
est: 2.06B (-62.1%)
|
1.17B
est: 829.07M (+40.9%)
|
345.10M
est: 1.09B (-68.3%)
|
5.21B
est: 449.10M (+1,059.7%)
|
2.56B
est: 4.50B (-43.2%)
|
1.53B
est: 2.20B (-30.2%)
|
4.68B
est: -356.11M (+1,413.8%)
|
4.47B
est: 5.13B (-12.8%)
|
9.07B
est: 2.07B (+339.0%)
|
9.47B
est: 7.80B (+21.5%)
|
9.00B
est: 2.51B (+258.4%)
|
8.78B
est: 11.76B (-25.3%)
|
10.10B
10.10B – 10.10B
-14.1% YoY
|
9.96B
9.96B – 9.96B
-1.4% YoY
|
15.01B
15.01B – 15.01B
+50.7% YoY
|
| SGA |
1.87B
est: 540.40M (+246.8%)
|
2.30B
est: 1.30B (+77.0%)
|
-42.30M
est: 772.60M (-105.5%)
|
3.14B
est: 408.24M (+670.0%)
|
4.19B
est: 2.41B (+73.6%)
|
7.34B
est: 3.97B (+84.8%)
|
8.42B
est: 3.29B (+156.3%)
|
10.92B
est: 18.83B (-42.0%)
|
12.22B
est: 15.06B (-18.8%)
|
4.85B
est: 18.34B (-73.6%)
|
5.24B
est: 17.30B (-69.7%)
|
5.52B
est: 1.97B (+180.8%)
|
6.46B
est: 18.72B (-65.5%)
|
7.02B
est: 20.49B (-65.7%)
|
7.16B
est: 1.26B (+468.1%)
|
7.64B
est: 1.08B (+604.5%)
|
8.62B
est: 1.76B (+388.5%)
|
9.66B
est: 2.10B (+359.6%)
|
10.43B
est: 2.26B (+361.5%)
|
11.86B
est: 1.91B (+519.3%)
|
22.19B
22.19B – 22.19B
+1,058.5% YoY
|
22.60B
22.60B – 22.60B
+1.9% YoY
|
24.30B
24.30B – 24.30B
+7.5% YoY
|
| EPS |
8.66
est: 4.50 (+92.3%)
|
9.61
est: 5.79 (+65.9%)
|
11.24
est: 3.71 (+203.1%)
|
5.87
est: -1.70 (+445.4%)
|
53.64
est: 0.98 (+5,381.9%)
|
18.06
est: 6.28 (+187.4%)
|
18.03
est: 8.00 (+125.5%)
|
11.91
est: 15.48 (-23.1%)
|
4.44
est: 2.33 (+90.2%)
|
6.64
est: 4.00 (+66.0%)
|
1.95
est: 7.30 (-73.3%)
|
29.44
est: 12.60 (+133.7%)
|
14.46
est: 12.40 (+16.6%)
|
8.67
est: 18.90 (-54.1%)
|
26.43
est: -2.00 (+1,421.5%)
|
25.27
est: 7.50 (+236.9%)
|
51.17
est: 11.60 (+341.1%)
|
53.39
est: 23.00 (+132.1%)
|
50.68
est: 14.10 (+259.4%)
|
49.47
est: 65.90 (-24.9%)
|
56.60
56.60 – 56.60
-14.1% YoY
|
55.80
55.80 – 55.80
-1.4% YoY
|
84.10
84.10 – 84.10
+50.7% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-27 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-26 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-25 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-22 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-21 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-20 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-19 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-18 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-15 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-14 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-13 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-12 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-11 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-08 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-07 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-06 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-05 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-04 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-30 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-29 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-28 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-27 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-24 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-23 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-22 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-21 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-20 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-17 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-16 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Muthiah Murugappan | Chief Executive Officer & Whole-Time Director | 36M | male |
| Biswa Mohan Rath | Company Secretary, Compliance Officer & Senior Vice President of Legal | 5M | male |
| Balaji | Senior Vice President & Head of Manufacturing | — | male |
| S. Ramakrishnan | Business Head of Nutraceuticals | — | male |
| V. R. Chandrasekar | Senior Assistant Vice President & Chief Information Officer | — | male |
| A. Stephen Francis | Senior Assistant Vice President of HR & IR | — | male |
| Y. Venkateshwarlu | Chief Financial Officer | — | male |
| Abdul Hakeem Ashiq | Chief Operating Officer of Sugar & Bio-fuel | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for EIDPARRY.NS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
